Non-Interventional Study To Investigate The Effectiveness, Safety And Utilization Of Vismodegib On Locally Advanced Basal Cell Carcinoma Under Real World Conditions (NIELS)

Study identification

• EU PAS number:
  EUPAS10089
• Study ID:
  30219
• Official title and acronym:
  Non-Interventional Study To Investigate The Effectiveness, Safety And Utilization Of Vismodegib On Locally Advanced Basal Cell Carcinoma Under Real World Conditions (NIELS)
• DARWIN EU® study:
  No
• Study countries:
  Germany
• Study description:
  STUDY TO INVESTIGATE THE EFFECTIVENESS, SAFETY AND UTILIZATION OF VISMODEGIB ON LOCALLY ADVANCED BASAL CELL CARCINOMA UNDER REAL WORLD CONDITIONS
• Study status:
  Finalised

Research institutions and networks

Institutions

NA

Multiple centres: 30 centres are involved in the study

Study timelines

Date when funding contract was signed

Actual:27/01/2015

Study start date

Planned:15/09/2015

Actual:17/09/2015

Date of final study report

Actual:31/03/2019

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Roche

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable

Other study registration identification numbers and links

ML29670